OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The association between tumour heterogeneity and immune evasion mechanisms in hepatocellular carcinoma and its clinical implications
Kaina Chen, Timothy Wai Ho Shuen, Pierce K. H. Chow
British Journal of Cancer (2024) Vol. 131, Iss. 3, pp. 420-429
Open Access | Times Cited: 15

Showing 15 citing articles:

Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis
Baofa Yu, Wenxue Ma
Cytokine & Growth Factor Reviews (2024) Vol. 79, pp. 29-38
Closed Access | Times Cited: 10

Tumor-Specific Liquid Metal Nitric Oxide Nanogenerator for Enhanced Breast Cancer Therapy
Su Chen, Jianhan Lin, Cong Li, et al.
Asian Journal of Pharmaceutical Sciences (2025) Vol. 20, Iss. 2, pp. 101018-101018
Open Access | Times Cited: 1

Mitochondrial alterations and signatures in hepatocellular carcinoma
Tsung‐Hsien Chen, Shu-Hsien Lin, Ming‐Yang Lee, et al.
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Open Access

Integrating CT Radiomics and Clinical Features to Optimize TACE Technique Decision-Making in Hepatocellular Carcinoma
Max Masthoff, Maximilian Irle, Daniel Kaldewey, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 893-893
Open Access

Latent class analysis‐derived classification for cancer‐specific death stratification of hepatocellular carcinoma
Xiaoyan Jiang, Qianyuan Zhang, Zhong Zheng, et al.
International Journal of Cancer (2025)
Closed Access

NAE1 protein: a prognostic, immunomodulatory, and therapeutic biomarker associated with neddylation in hepatocellular carcinoma
Yong Pan, Jinyao Dai, Yi Liu, et al.
International Journal of Biological Macromolecules (2025) Vol. 310, pp. 143539-143539
Closed Access

Efficacy and safety of radiotherapy combined with immune checkpoint inhibitors for advanced or unresectable hepatocellular carcinoma: a systematic review and meta-analysis
Qibin Wu, Xia Zhao, Chong Yang, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104730-104730
Closed Access

Progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma
Tong Liu, Guorui Meng, Shihui Ma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

Global perspectives and hotspots of VEGF signaling pathway in Liver disease from 2008 to 2023: A bibliometric analysis and visualization
Yi He, Jiaxin Huang, Xiaofan Liang, et al.
Heliyon (2024) Vol. 11, Iss. 1, pp. e41346-e41346
Open Access | Times Cited: 2

Editorial: Novel preclinical model, biomarker, treatment and drug delivery to address immune evasion in cancer
Chun‐Wai Mai, Zuzana Macek Jílková, Kamal Dua, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

Page 1

Scroll to top